UnitedHealthcare’s copay-only plan is booming, despite backlash over care denialsnews2025-03-04T11:00:49+00:00March 4th, 2025|Endpoints News|
23andMe rejects CEO’s second take-private offernews2025-03-04T08:57:23+00:00March 4th, 2025|Endpoints News|
Teladoc reports $1B net loss as it works to turn around its businessnews2025-02-27T15:25:56+00:00February 27th, 2025|Endpoints News|
Is the GLP-1 compounding boom over? Not exactlynews2025-02-25T15:34:25+00:00February 25th, 2025|Endpoints News|
Hims eyes growth in its weight loss business, despite end of semaglutide shortagenews2025-02-25T14:30:53+00:00February 25th, 2025|Endpoints News|
23andMe’s CEO submits bid to take company private for $74.7Mnews2025-02-24T16:35:50+00:00February 24th, 2025|Endpoints News|
